Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets |
| |
| Affiliation: | 1. Institut national de santé publique du Québec, Montreal, QC, Canada;2. University of Montreal Hospital Research Centre, Montreal, QC, Canada;3. Department of Anthropology, McGill University, Montreal, QC, Canada;4. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA;5. Université Claude Bernard de Lyon, Lyon, France;6. Department of Obstetrics and Gynecology, University of Sherbrooke Hospital Research Centre, Quebec, QC, Canada |
| |
| Abstract: | Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by severe cognitive impairment, inability to perform activities of daily living and mood changes. Statins, long known to be beneficial in conditions where dyslipidemia occurs by lowering serum cholesterol levels, also have been proposed for use in neurodegenerative conditions, including AD. However, it is not clear that the purported effectiveness of statins in neurodegenerative disorders is directly related to cholesterol-lowering effects of these agents; rather, the pleiotropic functions of statins likely play critical roles. The aim of this review is to provide an overview on the new discoveries about the effects of statin therapy on the oxidative and nitrosative stress levels as well as on the modulation of the heme oxygenase/biliverdin reductase (HO/BVR) system in the brain. We propose a novel mechanism of action for atorvastatin which, through the activation of HO/BVR-A system, may contribute to the neuroprotective effects thus suggesting a potential therapeutic role in AD and potentially accounting for the observation of decreased AD incidence with persons on statin. |
| |
| Keywords: | Alzheimer disease Biliverdin reductase Cognition Heme oxygenase Oxidative stress Statin |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
